Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) EVP Eric Swayze Sells 10,773 Shares

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Get Free Report) EVP Eric Swayze sold 10,773 shares of the stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $52.00, for a total transaction of $560,196.00. Following the transaction, the executive vice president now owns 32,516 shares in the company, valued […]

Related Keywords

Zurich ,Züsz ,Switzerland ,United States ,New Jersey ,America ,Eric Swayze ,Stifel Nicolaus ,Needham Company ,Quarter For Ionis Pharmaceuticals ,Ionis Pharmaceuticals ,News Ratings For Ionis Pharmaceuticals Daily ,Goldman Sachs Group ,Truist Financial Corp ,Ionis Pharmaceuticals Inc ,Hedge Funds Weigh In On Ionis Pharmaceuticals ,Ltd Zurich ,Jpmorgan Chase Co ,Ionis Pharmaceuticals Company Profile ,Nasdaq ,Bank Julius Baer Co ,Ionis Pharmaceuticals Trading Down ,Jersey Common Pension Fund ,Get Free Report ,Pharmaceuticals Trading Down ,Financial Corp ,Julius Baer ,Handelsbanken Fonder ,Ionis Pharmaceuticals Daily ,Nasdaq Ions ,Lions ,Medical ,46433010 ,Insider Trading ,Nsider Trades ,Stocks ,